United Therapeutics | UTHR - Current Assets


United Therapeutics reported $3.7B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Amarin USD 649.88M 21.55M Dec/2025
Ardelyx USD 382.32M 14.33M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Bayer EUR 32.91B 30M Dec/2025
BioCryst Pharmaceuticals USD 404.35M 48.66M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Emergent BioSolutions USD 679.5M 41.3M Dec/2023
Esperion Therapeutics USD 462.57M 102.11M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
Insmed USD 1.79B 137.6M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Lexicon Pharmaceuticals USD 101.9M 20.63M Dec/2025
Moderna USD 6.54B 54M Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Pfizer USD 46.92B 3.22B Sep/2025
PTC Therapeutics USD 2.27B 266.14M Dec/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
United Therapeutics USD 3.7B 208.5M Dec/2025
Vertex Pharmaceuticals USD 11.2B 631.4M Dec/2025